KARAKTERISTIK PENYAKIT KOMORBID PADA PASIEN INFEKSI COVID-19
DOI:
https://doi.org/10.30649/v5i2.178Keywords:
COVID-19, comorbidities, diseases, characteristicsAbstract
COVID-19 is an emerging global infection with a significant impact on people's lives. This study aims to describe the characteristics of comorbidities in COVID-19-infected patients at Sanjiwani Teaching Hospital and Kasih Ibu Hospital in Denpasar. The research method used was a descriptive, cross-sectional observational study involving 115 adult patients diagnosed with COVID-19 based on RT-PCR test results. Demographic data, symptoms, laboratory results, and comorbidities were recorded. The results showed that the majority of patients were over 60 years old, with fever (78.3%) as the most common complaint. Laboratory results indicated moderate COVID-19 severity (52%) and severe-critical (47.8%). The most common comorbidities found were hypertension and diabetes mellitus. This study highlights the importance of monitoring and managing comorbidities to improve clinical outcomes for COVID-19 patients.
References
1. Sohrabi C, Alsafi Z, O’neill N, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020;76:71-76.
2. Masyeni S, Nelwan EJ, Fatawy RM, et al. Clinical characteristics and outcomes of COVID-19 patients in Bali, Indonesia. PLoS One. 2022;17(6):e0269026. doi:10.1371/journal.pone.0269026
3. Masyeni S, Santoso MS, Widyaningsih PD, et al. Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia. Int J Infect Dis. 2021;102:152-154. doi:10.1016/j.ijid.2020.10.043
4. Fahriani M, Ilmawan M, Fajar JK, et al. Persistence of long COVID symptoms in. Narra J. 2021;1(2):1-14.
5. Hu L, Chen S, Fu Y, Gao Z, Long H, Ren HW. Risk Factors Associated with Clinical Outcomes in 323 Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, China. Clin Infect Dis. 2020;71(16):2089-2098.
6. Mudatsir M, Fajar JK, Wulandari L, et al. Predictors of COVID-19 severity: a systematic review and meta-analysis. F1000Research. 2020;9.
7. Yorike D, Kurniawan MR, Syafaat M. Analysis of D-Dimer Level and Prothombin Time (PT) Activated Prothombin Thromboplastin (APTT) on Heparin Administration to COVID-19 Patients. Indones J Med Lab Sci Technol. 2022;4(1):91-98. doi:10.33086/ijmlst.v4i1.2487
8. Rosalina I, Adrizain R, Sari CA, Alam A, Setiabudi D. Liver Function Profile of Pediatric Patients with Dengue Viral Infection Admitted to a Tertiary Referral Hospital during the COVID-19 Pandemic. Althea Med J. 2023;10(2):88-92. doi:10.15850/ijihs.v10n2.2954
9. Chatterjee S, Nalla L V, Sharma M, Sharma N, Singh AA, Malim FM. Association of COVID-19 with Comorbidities: An Update. ACS Pharmacol Transl Sci Am Chem Soc. 2023;6:334–54.
10. Zhou; F et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. Published online 2020. doi:10.1016/S0140-6736(20)30566-3
11. Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81(2):e16-e25.
12. Guan, W.J., Ni, Z.Y., Hu Y. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. doi:10.1056/NEJMoa2002032
13. Ejaz H, Alsrhani A, Zafar A, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020;13(12):1833-1839. doi:10.1016/j.jiph.2020.07.014
14. Megiorni F, Pontecorvi P, Gerini G, Anastasiadou E, Marchese C, Ceccarelli S. Sex-related factors in cardiovascular complications associated to covid-19. Biomolecules. 2022;1;12(1.
15. Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Saraswati Laksmi Dewi, Kartika Dewi R, Atmaja KS
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
